Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET

Company Participants

Seth Frank – Vice President, Investor Relations

Seth Blackley – Chief Executive Officer, Co-Founder & Board Member

John Johnson – Chief Financial Officer

Conference Call Participants

Ryan Daniels – William Blair

Kevin Caliendo – UBS

Unknown speaker – Guggenheim Partners

Charles Rhyee – TD Cowen

Jeff Garro – Stephens Inc

Richard Close – Canaccord Genuity

David Larsen – BTIG

Sean Dodge – RBC Capital Markets

Jessica Tassan – Piper Sandler


Welcome to the Evolent Earnings Conference Call for the quarter ended September 30th, 2023. As a reminder, this conference call is being recorded. Your hosts for the call today from Evolent are Seth Blackley, chief executive officer; and John Johnson, chief financial officer. This call will be archived and available later this evening and for the next week via the webcast on the company’s website, in the section entitled Investor Relations.

I will now hand the call to Seth Frank, Evolent’s vice president of investor relations. Please go ahead.

Seth Frank

Thank you, and good evening. This conference call will contain forward-looking statements under the U.S. federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations.

A description of some of the risks and uncertainties can be found in the company’s reports that are filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company’s results and outlook, please refer to our third-quarter press release issued earlier today. Finally, as a reminder, reconciliations of non-GAAP measures discussed during today’s call to the most direct comparable GAAP measures are available in the summary presentation available in the Investor Relations section of our website

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *